医学理论与实践
醫學理論與實踐
의학이론여실천
The Journal of Medical Theory and Practice
2014年
5期
576-578
,共3页
缺血缺氧性脑病%新生儿%亚低温%神经节苷脂注射液
缺血缺氧性腦病%新生兒%亞低溫%神經節苷脂註射液
결혈결양성뇌병%신생인%아저온%신경절감지주사액
Hypoxic-ischemic encephalopathy%Ganglioside
目的:观察早期亚低温联合单唾液酸四己糖神经节苷脂治疗对新生儿缺血缺氧性脑病(H IE )的临床疗效。方法:将90例 H IE患儿随机分为两组,对照组(45例)给予对症、支持治疗,观察组(45例)在对症、支持治疗基础上加用单唾液酸四己糖神经节苷脂联合早期亚低温治疗。观察两组患儿治疗前、后临床表现、新生儿神经行为评分(NB-NA)、CT表现等指标。结果:治疗后观察组与对照组相比较,患儿治疗前、后的心率恢复好于后者(P<0.05);治疗后NBNA评分,观察组明显高于对照组(P<0.01);观察组治疗后脑CT正常增多,异常减少。结论:早期亚低温联合神经节苷脂对新生儿HIE的疗效显著,值得临床推广。
目的:觀察早期亞低溫聯閤單唾液痠四己糖神經節苷脂治療對新生兒缺血缺氧性腦病(H IE )的臨床療效。方法:將90例 H IE患兒隨機分為兩組,對照組(45例)給予對癥、支持治療,觀察組(45例)在對癥、支持治療基礎上加用單唾液痠四己糖神經節苷脂聯閤早期亞低溫治療。觀察兩組患兒治療前、後臨床錶現、新生兒神經行為評分(NB-NA)、CT錶現等指標。結果:治療後觀察組與對照組相比較,患兒治療前、後的心率恢複好于後者(P<0.05);治療後NBNA評分,觀察組明顯高于對照組(P<0.01);觀察組治療後腦CT正常增多,異常減少。結論:早期亞低溫聯閤神經節苷脂對新生兒HIE的療效顯著,值得臨床推廣。
목적:관찰조기아저온연합단타액산사기당신경절감지치료대신생인결혈결양성뇌병(H IE )적림상료효。방법:장90례 H IE환인수궤분위량조,대조조(45례)급여대증、지지치료,관찰조(45례)재대증、지지치료기출상가용단타액산사기당신경절감지연합조기아저온치료。관찰량조환인치료전、후림상표현、신생인신경행위평분(NB-NA)、CT표현등지표。결과:치료후관찰조여대조조상비교,환인치료전、후적심솔회복호우후자(P<0.05);치료후NBNA평분,관찰조명현고우대조조(P<0.01);관찰조치료후뇌CT정상증다,이상감소。결론:조기아저온연합신경절감지대신생인HIE적료효현저,치득림상추엄。
Objective :To observe the curative effect on monosialoganglioside and early mild hypothermia in treatment of neonatal hypoxic-ischemic encephalopathy .Methods:90 cases of HIE were randomly divided into 2 groups:control group(n=45 ,treated with symptomatic treatment and supportive treatment )and the observation group(n=45 ,treated with symptomatic and supportive therapy and monosialoganglioside and early mild hypothermia ) .The clinical symp-toms and and the scores of neonatal behavioral neurological assessment (NBNA ) and CT performance of two groups were observed and compared .Results:The heart rate recovery of control group were significantly (P<0 .05) .Neonatal behavioral neurological assessment (NBNA) score and normal CT performance was higher in the observation group than that in the control group(P<0 .01) .Conclusion:The curative effect of treating HIE with monosialoganglioside and early mild hypothermia was obvious ,which was worthy clinical application .